{"id":19320,"date":"2021-12-23T10:24:35","date_gmt":"2021-12-23T15:24:35","guid":{"rendered":"https:\/\/medicarereport.org\/?p=19320"},"modified":"2021-12-23T10:24:37","modified_gmt":"2021-12-23T15:24:37","slug":"fda-authorizes-mercks-covid-19-pill-but-stresses-its-use-should-be-limited","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=19320","title":{"rendered":"FDA authorizes Merck\u2019s Covid-19 pill, but stresses its use should be limited"},"content":{"rendered":"\n<p>(By Matthew Herper for ST<em>A<\/em>T)<\/p>\n\n\n\n<p>The Food and Drug Administration on Thursday granted emergency authorization to Merck\u2019s molnupiravir, an antiviral pill shown to reduce hospitalization and death in cases of Covid-19, but only in cases where other FDA-authorized Covid treatments are not accessible or clinically appropriate.  Continue reading <a href=\"https:\/\/www.statnews.com\/2021\/12\/23\/fda-authorizes-mercks-covid-19-pill-but-stresses-its-use-should-be-limited\/\" data-type=\"URL\" data-id=\"https:\/\/www.statnews.com\/2021\/12\/23\/fda-authorizes-mercks-covid-19-pill-but-stresses-its-use-should-be-limited\/\">here&#8230;<\/a><\/p>\n\n\n\n<p class=\"has-text-align-center\"><img loading=\"lazy\" decoding=\"async\" width=\"275\" height=\"29\" class=\"wp-image-4372\" style=\"width: 275px;\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png\" alt=\"\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png 453w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png 300w\" sizes=\"auto, (max-width: 275px) 100vw, 275px\" \/><\/p>\n\n\n\n<pre class=\"wp-block-preformatted\"><strong>Notice:<\/strong> The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>(By Matthew Herper for STAT) The Food and Drug Administration on Thursday granted emergency authorization to Merck\u2019s molnupiravir, an antiviral<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[31,52,15],"tags":[],"class_list":["post-19320","post","type-post","status-publish","format-standard","hentry","category-fda","category-pandemic","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/19320","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=19320"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/19320\/revisions"}],"predecessor-version":[{"id":19321,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/19320\/revisions\/19321"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=19320"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=19320"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=19320"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}